USD 0.0
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | 502.43 Thousand CAD | 13.97% |
2021 | 440.84 Thousand CAD | 42.8% |
2020 | 308.7 Thousand CAD | 0.46% |
2019 | 307.3 Thousand CAD | -67.85% |
2018 | 955.87 Thousand CAD | -29.43% |
2017 | 1.35 Million CAD | 72.49% |
2016 | 785.25 Thousand CAD | 25.22% |
2015 | 627.09 Thousand CAD | -54.04% |
2014 | 1.36 Million CAD | 137.14% |
2013 | 575.31 Thousand CAD | 133.87% |
2012 | 246 Thousand CAD | -7.48% |
2011 | 265.9 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q3 | 473.22 Thousand CAD | 9.99% |
2023 Q2 | 430.23 Thousand CAD | -19.25% |
2023 Q1 | 532.79 Thousand CAD | 6.04% |
2022 FY | 502.43 Thousand CAD | 13.97% |
2022 Q3 | 369.24 Thousand CAD | 8.81% |
2022 Q4 | 502.43 Thousand CAD | 36.07% |
2022 Q1 | 348.87 Thousand CAD | -20.86% |
2022 Q2 | 339.35 Thousand CAD | -2.73% |
2021 Q2 | 295.32 Thousand CAD | 9.07% |
2021 FY | 440.84 Thousand CAD | 42.8% |
2021 Q4 | 440.84 Thousand CAD | 47.4% |
2021 Q1 | 270.77 Thousand CAD | -12.29% |
2021 Q3 | 299.07 Thousand CAD | 1.27% |
2020 FY | 308.7 Thousand CAD | 0.46% |
2020 Q1 | 298.48 Thousand CAD | -2.87% |
2020 Q4 | 308.7 Thousand CAD | 25.35% |
2020 Q3 | 246.27 Thousand CAD | -36.82% |
2020 Q2 | 389.77 Thousand CAD | 30.59% |
2019 Q4 | 307.3 Thousand CAD | 38.44% |
2019 FY | 307.3 Thousand CAD | -67.85% |
2019 Q1 | 878.59 Thousand CAD | -8.09% |
2019 Q2 | 311 Thousand CAD | -64.6% |
2019 Q3 | 221.98 Thousand CAD | -28.62% |
2018 FY | 955.87 Thousand CAD | -29.43% |
2018 Q2 | 936.39 Thousand CAD | 1.06% |
2018 Q1 | 926.56 Thousand CAD | -31.59% |
2018 Q4 | 955.87 Thousand CAD | -12.7% |
2018 Q3 | 1.09 Million CAD | 16.93% |
2017 Q2 | 628.63 Thousand CAD | -28.49% |
2017 Q1 | 879.06 Thousand CAD | 11.95% |
2017 FY | 1.35 Million CAD | 72.49% |
2017 Q4 | 1.35 Million CAD | 56.22% |
2017 Q3 | 867.03 Thousand CAD | 37.92% |
2016 Q2 | 1.14 Million CAD | 68.17% |
2016 Q1 | 678.07 Thousand CAD | 8.13% |
2016 FY | 785.25 Thousand CAD | 25.22% |
2016 Q3 | 1.17 Million CAD | 3.19% |
2016 Q4 | 785.25 Thousand CAD | -33.27% |
2015 Q1 | 1.46 Million CAD | 7.23% |
2015 FY | 627.09 Thousand CAD | -54.04% |
2015 Q2 | 573.29 Thousand CAD | -60.81% |
2015 Q4 | 627.09 Thousand CAD | 4.58% |
2015 Q3 | 599.6 Thousand CAD | 4.59% |
2014 Q3 | 581.86 Thousand CAD | 1.09% |
2014 Q2 | 575.61 Thousand CAD | 10.43% |
2014 Q4 | 1.36 Million CAD | 134.47% |
2014 FY | 1.36 Million CAD | 137.14% |
2014 Q1 | 521.24 Thousand CAD | -9.4% |
2013 FY | 575.31 Thousand CAD | 133.87% |
2013 Q3 | 242.17 Thousand CAD | 99.96% |
2013 Q4 | 575.31 Thousand CAD | 137.56% |
2013 Q1 | 225.4 Thousand CAD | -8.37% |
2013 Q2 | 121.1 Thousand CAD | -46.27% |
2012 FY | 246 Thousand CAD | -7.48% |
2012 Q2 | 46.19 Thousand CAD | -64.39% |
2012 Q4 | 246 Thousand CAD | 13.3% |
2012 Q1 | 129.71 Thousand CAD | -51.22% |
2012 Q3 | 217.12 Thousand CAD | 369.97% |
2011 FY | 265.9 Thousand CAD | 0.0% |
2011 Q4 | 265.9 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Energy Corporation | 4.34 Million USD | 88.442% |
Earth Alive Clean Technologies Inc. | 994.33 Thousand USD | 49.471% |
Igene Biotechnology, Inc. | 7.5 Million USD | 93.303% |
Lotus Bio-Technology Development Corp. | - USD | -Infinity% |
MagIndustries Corp. | 99.83 Million USD | 99.497% |
Itafos Inc. | 346.68 Million USD | 99.855% |
Potash America, Inc. | 2.33 Million USD | 78.451% |
Yara International ASA | 8.45 Billion USD | 99.994% |
Yara International ASA | 8.43 Billion USD | 99.994% |